Abilify and Haemolytic anaemia - a phase IV clinical study of FDA data

Summary:

Haemolytic anaemia is reported as a side effect among people who take Abilify (aripiprazole), especially for people who are male, 30-39 old, have been taking the drug for 1 - 6 months also take Lamictal, and have Schizophrenia.

The phase IV clinical study analyzes which people have Haemolytic anaemia when taking Abilify. It is created by eHealthMe based on reports of 97,308 people who have side effects when taking Abilify from the FDA, and is updated regularly.

What is Abilify?

Abilify has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 101,456 Abilify users. Check the latest studies of Abilify.

What is Haemolytic anaemia?

Haemolytic anaemia (anaemia due to haemolysis) is found to be associated with 780 drugs and 1,045 conditions by eHealthMe. Check the latest studies of Haemolytic anaemia.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

97,308 people reported to have side effects when taking Abilify.
Among them, 36 people (0.04%) have Haemolytic anaemia.

Among these 36 people:

How long have people been on Abilify when they have Haemolytic anaemia? *

What is the gender of people who have Haemolytic anaemia when taking Abilify? *

female: 38.71 %
male: 61.29 %

What is the age of people who have Haemolytic anaemia when taking Abilify? *

What are other drugs people take besides Abilify? *

What are other side effects people have besides Haemolytic anaemia? *

Weakness: 6 people, 16.67%
Dyspnea Exertional: 4 people, 11.11%
White Blood Cell Count Decreased: 3 people, 8.33%
Drug Hypersensitivity: 3 people, 8.33%
Dyspnea (difficult or laboured breathing): 3 people, 8.33%
Hypokalemia (low potassium): 3 people, 8.33%
Urticaria (rash of round, red welts on the skin that itch intensely): 3 people, 8.33%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 2 people, 5.56%
Headache (pain in head): 2 people, 5.56%
Fever: 2 people, 5.56%

What are the existing conditions these people have? *

Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 6 people, 16.67%
Stress And Anxiety: 2 people, 5.56%
B Precursor Type Acute Leukaemia (lymphoid cancer): 2 people, 5.56%
Chronic Thyroiditis (long lasting inflammation of thyroid gland): 2 people, 5.56%
Constipation: 2 people, 5.56%
Enterocolitis (inflammation of the digestive tract, involving enteritis of the small intestine and colitis of the colon): 2 people, 5.56%
Hepatitis C: 2 people, 5.56%
Hypoaesthesia (reduced sense of touch or sensation): 2 people, 5.56%
Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection): 2 people, 5.56%
Hypokalemia (low potassium): 2 people, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Abilify and have Haemolytic anaemia?

- Check whether Haemolytic anaemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Abilify:

Abilify (101,456 reports)

Browse all side effects of Abilify:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Haemolytic anaemia:

Haemolytic anaemia (780 drugs)

Browse all the conditions that are associated with Haemolytic anaemia:

Haemolytic anaemia (1,045 conditions)

Related publications that referenced our studies

Cetin, M., Celik, M., Cakici, M., Polat, M., & Suner, A, "Aripiprazole-Induced Hoarseness", Turk Psikiyatri Dergisi, 2018 Jan .
Cetin M, Celik M, Cakici M, Polat M, Suner A, "Aripiprazole induced non-cardiogenic pulmonary edema: a case report", Turk Psikiyatri Dergisi, 2014 Dec .
Cetin, M., Celik, M., Cakici, M., Polat, M., & Suner, A, "Aripiprazole-Induced Hoarseness", Turk Psikiyatri Dergisi, 2018 Jan .
Cetin M, Celik M, Cakici M, Polat M, Suner A, "Aripiprazole induced non-cardiogenic pulmonary edema: a case report", Turk Psikiyatri Dergisi, 2014 Dec .

How the study uses the data?

The study uses data from the FDA. It is based on aripiprazole (the active ingredients of Abilify) and Abilify (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.